Coverage
-
January 20, 2016
A California federal judge on Wednesday ended a suit in which Allergan Inc. alleged that Ferrum Ferro Capital LLC's bid to invalidate a patent for a glaucoma drug under the America Invents Act amounted to extortion, after previously finding no subject matter jurisdiction.
4 other articles on this case.
View all »